Faers - Open Access .click

Results 111 to 120 of about 9,302 (232)

Investigation of Adverse Events Associated with Predicted GnRHR Agonists Using the FAERS Database

Gonadotropin-releasing hormone receptor (GnRHR) agonists are widely used therapeutically, yet their adverse event profile remains insufficiently characterized.
Yoshihiro Uesawa, Yui Migura
core +1 more source

sj-docx-4-cms-10.1177_12034754241239269 – Supplemental material for Retinoids and Risk: A FAERS Database Study of Topical Retinoids

Supplemental material, sj-docx-4-cms-10.1177_12034754241239269 for Retinoids and Risk: A FAERS Database Study of Topical Retinoids by Simona A. Alomary, Mingzhuo Pei and Shari R.
Shari R. Lipner (7524403) +2 more
core +1 more source

Signal mining and analysis of adverse events of Brentuximab Vedotin base on FAERS and JADER databases.

PLoS ONE
ObjectivesBrentuximab Vedotin (BV) is a novel antibody-drug conjugate (ADC) approved for the treatment of classical Hodgkin's lymphoma and systemic anaplastic large cell lymphoma.
Feilong Tan, Yanhua Li, Hongying Xia, Wenjie Yin +3 more
doaj +1 more source

Safety assessment of Tafamidis: a real-world pharmacovigilance study of FDA adverse event reporting system (FAERS) events

SAFETY ASSESSMENT OF TAFAMIDIS: A REAL-WORLD PHARMACOVIGILANCE STUDY OF FDA ADVERSE EVENT REPORTING SYSTEM (FAERS) EVENTS Safety assessment of Tafamidis: a real-world pharmacovigilance study of FDA adverse event reporting system (FAERS) events / Li ...
Li, Yidan +4 more
core

Suicide adverse events associated with zopiclone and eszopiclone: A pharmacovigilance analysis based on FAERS, JADER and CVARD.

PLoS ONE
BackgroundSuicide adverse events are a serious concern with zopiclone and eszopiclone. This study assessed the risk of such events by mining data from the FAERS, JADER, and CVARD databases.MethodsThe analysis included reports from Q1 2004 to Q4 2024 for ...
Yinpeng Xu, Fang Li, Mei Zhang, Li Huang
doaj +1 more source

Incidence and Frequency of Immune-Related Nephropathy in Patients Treated with Immune Checkpoint Inhibitors A FAERS Database Analysis (2020–2024)

INTRODUCTIONImmune checkpoint inhibitors (ICIs) have significantlyimproved survival in various solid tumors. With theincreasing use of these agents, the number ofautoimmune toxicities—known as immune-relatedadverse events (irAEs)—has risen.The incidence ...
Alan, Özkan, Mütiş Alan, Aydan
core +1 more source

sj-docx-3-cms-10.1177_12034754241239269 – Supplemental material for Retinoids and Risk: A FAERS Database Study of Topical Retinoids

Supplemental material, sj-docx-3-cms-10.1177_12034754241239269 for Retinoids and Risk: A FAERS Database Study of Topical Retinoids by Simona A. Alomary, Mingzhuo Pei and Shari R.
Shari R. Lipner (7524403) +2 more
core +1 more source

Toxicity spectrum of pegvaliase: A pharmacovigilance analysis using the FAERS database

Orphanet Journal of Rare Diseases
Objective This research aimed to assess the safety of pegvaliase through analyzed the data from the FAERS database, thus providing a theoretical foundation for the rational and safe application of pegvaliase in clinical settings.
Luyao Xu +5 more
doaj +1 more source

Kidney adverse events associated with Calcineurin Inhibitor: a real-world study based on the FAERS database and network pharmacology

This is the supplementary materials of "Kidney adverse events associated with Calcineurin Inhibitor: a real-world study based on the FAERS database and network pharmacology" on Nov.5th ...
Liang, YaoYun
core +1 more source

sj-docx-2-cms-10.1177_12034754241239269 – Supplemental material for Retinoids and Risk: A FAERS Database Study of Topical Retinoids

Supplemental material, sj-docx-2-cms-10.1177_12034754241239269 for Retinoids and Risk: A FAERS Database Study of Topical Retinoids by Simona A. Alomary, Mingzhuo Pei and Shari R.
Shari R. Lipner (7524403) +2 more
core +1 more source

pharmacovigilance
medicine
adverse event

disproportionality analysis
safety
data mining

adverse events
vigiaccess